GRENEVIA/ PLFAMUR00012 /
08/10/2024 17:00:00 | Chg. -0.01 | Volume | Bid21:10:00 | Demandez à21:10:00 | Capitalisation boursière | Dividende Y. | Rapport P/E |
---|---|---|---|---|---|---|---|
1.98PLN | -0.40% | 86,523 Chiffrre d'affaires: 170,550.64 |
-Bid taille: - | -Ask la taille: - | 1.14 Mrd.PLN | - | 7.93 |
Newsfile Corp
23:41
INVESTOR DEADLINE APPROACHING: Faruqi & Faruqi, LLP Investigates Claims on Behalf of Investors of Ex...
Newsfile Corp
23:29
INVESTOR DEADLINE APPROACHING: Faruqi & Faruqi, LLP Investigates Claims on Behalf of Investors of Do...
Newsfile Corp
23:29
INVESTOR DEADLINE APPROACHING: Faruqi & Faruqi, LLP Investigates Claims on Behalf of Investors of Al...
Newsfile Corp
23:24
INVESTOR DEADLINE APPROACHING: Faruqi & Faruqi, LLP Investigates Claims on Behalf of Investors of Ne...
Newsfile Corp
23:15
ROSEN, TRUSTED INVESTOR COUNSEL, Encourages STMicroelectronics N.V. Investors to Secure Counsel Befo...
Newsfile Corp
23:00
VIDEO - CEO Clips - CMI Mortgage Investments: Specialized Private Lending Solutions for Canadian Rea...
Newsfile Corp
22:50
Une représentante du Jennifer Landa Breast Cancer Visiting Lectureship ferme les marchés
Newsfile Corp
22:01
Cardiol Therapeutics Files Preliminary Prospectus Supplement for Proposed Public Offering of Common ...
Newsfile Corp
21:17
FINAL DEADLINE ALERT: Faruqi & Faruqi, LLP Investigates Claims on Behalf of Investors of NANO Nuclea...
Newsfile Corp
21:13
FINAL DEADLINE ALERT: Faruqi & Faruqi, LLP Investigates Claims on Behalf of Investors of Moderna
Newsfile Corp
20:48
Vici Health Sciences Announces Launch of Phase I, Phase II, and Phase III Clinical Supplies Manufact...
- La première page
- Retour
- 1
- 2
- 3
- 4
- Suivant
- La dernière page